The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 2-UK-made AstraZeneca vaccines sent to Australia - Sydney Morning Herald

Thu, 08th Apr 2021 06:53

(Adds source-based comments)

LONDON, April 8 (Reuters) - Hundreds of thousands of doses
of AstraZeneca vaccine have been flown to Australia from
Britain but the source of the shipments was kept quiet to avoid
any controversy in the United Kingdom, the Sydney Morning Herald
said.

The first 300,000 British-made doses landed at Sydney
airport on February 28 – a month after the European Commission
adopted curbs on the export of vaccines produced in the EU, the
newspaper said.

Another large batch arrived on an Emirates passenger plane
in March, well after Italy and the European Commission formally
blocked an application by AstraZeneca to ship 250,000 doses to
Australia, it added.

The paper cited an unidentified British official as saying
the shipments to Australia were never at the expense of
Britain's vaccine rollout, one of the world's swiftest.

A spokesman for Australian Prime Minister Scott Morrison
declined to comment. A second source said Australia was
reluctant to confirm or deny the report.

"For reasons of supply chain integrity and national
security, we do not advise the origins of particular vaccine
shipments," said the source, who sought anonymity in the absence
of authority to speak on the matter.
(Reporting by Guy Faulconbridge in London and Canberra; Editing
by Jacqueline Wong, Sarah Young and John Stonestreet)

Related Shares

More News
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030 *

21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatm...

21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating seve...

20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.